Supernus enters depression drug market with up to $795 million Sage deal - Reuters

Reuters | June 16, 2025, 8:47 a.m. | Original
Supernus enters depression drug market with up to $795 million Sage deal Reuters
Crypto group Tron to go public in US via reverse-merger with SRM - TradingView Brazil's economic activity exceeds expectations ahead of interest rate decision - TradingView